GSK CEO Emma Walmsley gave an upbeat assessment of the British drugmaker's new respiratory syncytial virus (RSV) vaccine on ...

Respiratory syncytial virus, or RSV, is an upper respiratory infection that can cause serious complications, particularly for older adults and infants. But for the first time, there's a vaccine that ...

Federal officials have been working with companies to find ways to boost the supply of the new vaccine for newborns.

As the battle between new respiratory syncytial virus (RSV) vaccines heats up, GSK is “delighted” with the progress it's made ...

Pregnant women and their babies and adults over 60 years old can be more protected from respiratory syncytial virus, or RSV, ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that spreads seasonally. A new drug and several vaccines that prevent the infection have recently come to market. Here's what you ...

RSV is a common illness among infants. According to experts, 80% of babies catch it within their first year of life.

Respiratory syncytial virus, or RSV, is a common illness among young kids. Eighty percent of babies catch it within their first year of life. For some, it can be serious and require hospitalization.

TAMPA, Fla. - Respiratory syncytial virus, more commonly known as RSV, is a respiratory virus that infects the lungs and breathing passages. It affects all age groups, but can be especially serious ...

Medical professionals and politicians like U.S. Sen. Richard Blumenthal this week said people looking to prevent a common respiratory illness that hits hardest among young children and the elderly are ...

Parents struggle to find newly-approved RSV vaccine for babies. Pediatrician explains why. Parents struggle to find newly-approved RSV vaccine for babies. Pediatrician explains why. 03:27 ...

NEW YORK/LONDON (Reuters) -GSK CEO Emma Walmsley gave an upbeat assessment of the British drugmaker's new respiratory ...